On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...